AwardTape · Defense awards · Medical · Drugs and biologicals · W81K0025FA195
W81K0025FA195: $3.2M delivery order to Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation holds a delivery order from Department of the Army with $3.2M obligated since Oct 2023, against a ceiling of $3.2M. Latest action Jan 30, 2026.
Lutathera and pluvicto
| PIID | W81K0025FA195 |
|---|---|
| Type | delivery order |
| Parent award | W81K0024D0004 |
| Company | Novartis Pharmaceuticals Corporation |
| Agency | Department of the Army |
| Contracting office | W40M MRC0 WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325412 PHARMACEUTICAL PREPARATION MANUFACTURING |
| Obligated since Oct 2023 | $3.2M |
| Total obligated (lifetime) | $3.2M |
| Ceiling (base and all options) | $3.2M |
| Base date | Aug 18, 2025 |
| Latest action | Jan 30, 2026 |
| End date | Sep 30, 2026 |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial